# Patrinia villosa (Thunb.) Juss alleviates CCL4-induced acute liver injury by restoring bile acid levels and inhibiting apoptosis/autophagy

**Authors:** Ji-Feng Ye, Wei Liu, Qishu Hou, Shu-Qi Bai, Zheng Xiang, Jiaqi Wang, Liman Qiao

PMC · DOI: 10.3389/fphar.2024.1409971 · 2024-05-22

## TL;DR

This study shows that Patrinia villosa protects the liver from injury by restoring bile acid levels and reducing cell death and autophagy.

## Contribution

The paper first reveals how Patrinia villosa alleviates CCl4-induced liver injury through bile acid regulation and inhibition of apoptosis/autophagy.

## Key findings

- PV restored elevated AST, ALT, and T-BIL levels in CCl4-treated rats.
- PV reversed CCl4-induced changes in six bile acids and reduced liver inflammation.
- PV inhibited apoptosis in liver tissue and autophagy in HepG2 cells.

## Abstract

Patrinia villosa (Thunb.) Juss is one of the plant resources of the famous traditional Chinese medicine “Bai jiang cao (herba patriniae),” and it is considered to function at the liver meridian, thereby treating diseases of the liver as demonstrated by the traditional theory of TCM. Unfortunately, the therapeutic mechanism of the whole plant of PV is so far unknown.

UPLC QTOF-MS/MS was used to analyze the profile of PV. Male Sprague–Dawley rats were categorized into five groups, and PV groups (125 and 375 mg/kg) were administered by oral gavage for seven consecutive days. The model of liver injury was induced by intraperitoneal injection of 40% CCl4 oil solution. H&E staining was performed for histological evaluation. The ELISA method was used to assess the serum level of ALT, AST, and T-BIL. Serum and liver bile acid (BA) profiling was analyzed by LC-MS/MS. TUNEL-stained liver sections were used to monitor apoptosis caused by CCl4. HepG2 cells were used to detect autophagy caused by CCl4.

A total of 16 compounds were identified from the 70% methanol extract of PV. PV (125 and 375 mg/kg) could reverse the ectopic overexpression of AST, ALT, and T-BIL caused by CCl4 administration. H&E staining indicated that PV (125 and 375 mg/kg) could reduce the infiltration of inflammatory cells and restore liver tissue and hepatocyte structures. Six bile acids, including DCA, HDCA, GCA, TCA, TCDCA, and TUDCA, were significantly altered both in the serum and liver tissue after CCl4 administration, and the level of all these six bile acids was restored by PV treatment. Moreover, PV inhibited apoptosis caused by CCl4 stimulation in liver tissue and suppressed autophagy in HepG2 cells treated with CCl4.

The results in this paper for the first time reveal the alteration of the bile acid profile in CCl4-induced liver injury and demonstrate that inhibiting apoptosis and autophagy was involved in P. villosa-elicited liver protection, providing a scientific basis for the clinical utilization of P. villosa as a natural hepatic protective agent.

## Linked entities

- **Chemicals:** CCl4 (PubChem CID 5943), ALT (PubChem CID 10219674), DCA (PubChem CID 6597), HDCA (PubChem CID 5283820), TCA (PubChem CID 6421), TCDCA (PubChem CID 387316), TUDCA (PubChem CID 9848818)

## Full-text entities

- **Diseases:** liver injury (MESH:D017093), inflammatory (MESH:D007249), acute liver injury (MESH:D017114), diseases of the liver (MESH:D008107)
- **Chemicals:** PV (MESH:D010404), TUDCA (MESH:C031655), BA (MESH:D001647), methanol (MESH:D000432), TCA (MESH:D014238), H&amp;E (MESH:D006371), CCl4 oil (-), CCl4 (MESH:D002251)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Patrinia villosa (species) [taxon 183944]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11150553/full.md

---
Source: https://tomesphere.com/paper/PMC11150553